Profund Advisors LLC Decreases Stake in Molina Healthcare, Inc. (NYSE:MOH)

Profund Advisors LLC decreased its position in Molina Healthcare, Inc. (NYSE:MOH) by 9.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,771 shares of the company’s stock after selling 670 shares during the period. Profund Advisors LLC’s holdings in Molina Healthcare were worth $969,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the business. Advisors Preferred LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at approximately $37,000. Cornerstone Advisors Inc. grew its position in shares of Molina Healthcare by 3,577.8% during the 1st quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock valued at $47,000 after acquiring an additional 322 shares during the period. Financial Gravity Wealth Inc. grew its position in shares of Molina Healthcare by 35.0% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 501 shares of the company’s stock valued at $72,000 after acquiring an additional 130 shares during the period. Bremer Bank National Association bought a new position in shares of Molina Healthcare during the 1st quarter valued at approximately $87,000. Finally, Northwestern Mutual Wealth Management Co. grew its position in shares of Molina Healthcare by 108.6% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 997 shares of the company’s stock valued at $142,000 after acquiring an additional 519 shares during the period. Hedge funds and other institutional investors own 96.76% of the company’s stock.

MOH traded up $1.04 on Monday, hitting $116.00. The company’s stock had a trading volume of 10,269 shares, compared to its average volume of 516,779. The company’s 50 day simple moving average is $130.28 and its 200-day simple moving average is $136.20. The firm has a market cap of $7.13 billion, a P/E ratio of 10.48, a price-to-earnings-growth ratio of 1.03 and a beta of 1.20. Molina Healthcare, Inc. has a 12 month low of $105.28 and a 12 month high of $159.00. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.85.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Tuesday, July 30th. The company reported $3.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.56 by $0.55. The company had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.08 billion. Molina Healthcare had a net margin of 4.48% and a return on equity of 51.49%. Molina Healthcare’s revenue for the quarter was down 14.1% on a year-over-year basis. During the same period last year, the firm earned $3.08 EPS. Equities analysts predict that Molina Healthcare, Inc. will post 11.51 earnings per share for the current fiscal year.

In other Molina Healthcare news, Director Ronna Romney sold 375 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $131.63, for a total value of $49,361.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.77% of the stock is owned by company insiders.

A number of research analysts have recently weighed in on the stock. BMO Capital Markets raised shares of Molina Healthcare from a “market perform” rating to an “outperform” rating and increased their target price for the company from $154.00 to $200.00 in a research report on Monday, June 3rd. Morgan Stanley reduced their target price on shares of Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating for the company in a research report on Friday, August 23rd. Barclays increased their target price on shares of Molina Healthcare from $140.00 to $149.00 and gave the company an “equal weight” rating in a research report on Friday, May 31st. Deutsche Bank assumed coverage on shares of Molina Healthcare in a research report on Thursday. They set a “buy” rating and a $145.00 target price for the company. Finally, ValuEngine downgraded shares of Molina Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $160.83.

Molina Healthcare Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

See Also: What is the return on assets (ROA) ratio?

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit